摘要
目的:观察氨溴索治疗新生儿胎粪吸入综合征的疗效。方法:76例新生儿胎粪吸入综合征患儿随机分为治疗组46例和对照组30例,治疗组在对照组常规治疗基础上加用氨溴索治疗。结果:治疗组总有效率91.3%,对照组总有效率为73.33%,两组比较差异有统计学意义(P<0.05)。治疗组紫绀消退时间[(1.85±0.67)d]和氧疗时间[(3.21±1.40)d]较对照组缩短,两组比较差异有统计学意义(P<0.01)。结论:氨溴索佐治新生儿胎粪吸入综合征疗效显著,安全性高,值得临床推广。
Objective： To observe the ambroxol treatment in neonatal meconium aspiration syndrome. Methods： Seventy-six eases of neonatal meeonium aspiration syndrome were randomly divided into a treatment group （46 cases） and a control group （30 cases）, with the treatment group having ambroxol in addition to the conventional therapy in treatment. Results： The total effective rate of the treatment group was 91.3%, the control group＇s effectiveness was 73.33%. The difference had statistical significance （P 〈 0.05 ）. In the treatment group, eyanosis subsided time [ （ 1.85 ± 0.67 ） d ] and oxygen therapy time [ （ 3.21 ± 1.40 ） d ] were shorter than those in the control group. The difference between the two groups had statistical significance （ P 〈 0.01 ）. Conclusions ： Injection ambroxol treatment of neonatal meeonium aspiration syndrome is effective, safe and worth popularizing.
出处
《儿科药学杂志》
CAS
2009年第2期24-25,共2页
Journal of Pediatric Pharmacy
关键词
氨溴索
新生儿
胎粪吸入综合征
Ambroxol
Newborns
Meeonium aspiration syndrome
